Quantum Cyber N.V. current report, Q4 FY2024

Business Context and Reporting Period

This Form 6-K filing by Mainz Biomed N.V. (noted as Quantum Cyber N.V. in metadata) covers the month of October 2024, with a report date of October 3, 2024. The registrant is a foreign private issuer headquartered in Mainz, Germany, filing under Rule 13a-16 of the Securities Exchange Act of 1934.

Key Financial Metrics

The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, or total debt levels. The document focuses exclusively on a specific capital transaction involving a convertible promissory note.

Material Changes

The primary material event is the modification of a convertible promissory note issued on September 26, 2023, to YA II PN, Ltd. Key changes include:

  • Floor Price Reduction: The company agreed to lower the conversion floor price from $2.00 to $0.20 for the current and future conversions of this note.
  • Share Issuance: Pursuant to a conversion notice issued on October 2, 2024, the company will issue up to 2,400,000 ordinary shares.
  • Conversion Terms: The conversion price is determined by the lower of $3.5424 or 92% of the average of the two lowest daily volume-weighted average prices during the eight trading days prior to conversion, subject to the new $0.20 floor.

Outlook, Risks, and Management Commentary

Management commentary is limited to the execution of the conversion notice and the agreement to adjust the floor price. The filing incorporates this report by reference into the Company's Registration Statement on Form F-3 (File No. 333-269091). No specific forward-looking guidance, risk factors, or contingencies beyond the dilution impact of the share issuance are detailed in this text.

Investor Verification Checklist

  • Verify the exact number of shares issued versus the maximum 2,400,000 authorized in the October 2 conversion.
  • Confirm the current market price relative to the new $0.20 floor price to assess immediate dilution impact.
  • Review the full terms of the September 26, 2023 Promissory Note to understand remaining principal and interest obligations.
  • Check the Form F-3 Registration Statement (File No. 333-269091) for broader context on the company's capital raising activities.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.